Pulmonary and cardiovascular effects of mefloquine methanesulfonate

Robert W. Caldwell, Clinton B. Nash

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Mefloquine methanesulfonate (WR-142, 490·CH3SO3H), a highly effective antimalarial agent, when infused at a dose rate of 1 mg/kg/ min for 20 min in the anesthetized dog, caused either little or no effect on the pulmonary and cardiovascular parameters measured during this drug infusion or in the following 3-hr observation period. However, dose rates of 2 and 3 mg/kg/min of mefloquine MS for 20 min did produce pulmonary and cardiovascular changes. The respiratory parameters which were observed to change were: (1) tidal volume, which fell during the drug infusion but then returned to control values during the remaining portion of the observation period; (2) respiratory rate, which rose during the drug infusion, but returned to control values; (3) dynamic airways resistance, which decreased during drug administration, but then rose above control values; (4) small gradual changes in blood pO2 and pCO2. The cardiovascular parameters observed to change were: (1) arterial blood pressure, which decreased during the drug infusion, but returned rapidly to control values; (2) cardiac contractile force, which diminished during the drug infusion and returned toward control values later in the observation period; (3) central venous pressure, which rose transiently during drug administration; (4) pulmonary artery pressure, which rose initially, but tended to decrease late in the observation period and returned to control values within a 24-hr period. The magnitude of the effects of mefloquine MS appeared to be more dependent on the dose rate of drug delivery than on the total dose delivered.

Original languageEnglish (US)
Pages (from-to)437-448
Number of pages12
JournalToxicology and Applied Pharmacology
Volume40
Issue number3
DOIs
StatePublished - Jun 1977

Fingerprint

Mefloquine
Drug infusion
Lung
Pharmaceutical Preparations
Observation
Blood pressure
Antimalarials
Drug delivery
Airway Resistance
Central Venous Pressure
methanesulfonic acid
Tidal Volume
Blood
Respiratory Rate
Pulmonary Artery
Arterial Pressure
Dogs
Pressure

ASJC Scopus subject areas

  • Toxicology
  • Pharmacology

Cite this

Pulmonary and cardiovascular effects of mefloquine methanesulfonate. / Caldwell, Robert W.; Nash, Clinton B.

In: Toxicology and Applied Pharmacology, Vol. 40, No. 3, 06.1977, p. 437-448.

Research output: Contribution to journalArticle

@article{2d3bbc5fc23646038e6409f9da424b23,
title = "Pulmonary and cardiovascular effects of mefloquine methanesulfonate",
abstract = "Mefloquine methanesulfonate (WR-142, 490·CH3SO3H), a highly effective antimalarial agent, when infused at a dose rate of 1 mg/kg/ min for 20 min in the anesthetized dog, caused either little or no effect on the pulmonary and cardiovascular parameters measured during this drug infusion or in the following 3-hr observation period. However, dose rates of 2 and 3 mg/kg/min of mefloquine MS for 20 min did produce pulmonary and cardiovascular changes. The respiratory parameters which were observed to change were: (1) tidal volume, which fell during the drug infusion but then returned to control values during the remaining portion of the observation period; (2) respiratory rate, which rose during the drug infusion, but returned to control values; (3) dynamic airways resistance, which decreased during drug administration, but then rose above control values; (4) small gradual changes in blood pO2 and pCO2. The cardiovascular parameters observed to change were: (1) arterial blood pressure, which decreased during the drug infusion, but returned rapidly to control values; (2) cardiac contractile force, which diminished during the drug infusion and returned toward control values later in the observation period; (3) central venous pressure, which rose transiently during drug administration; (4) pulmonary artery pressure, which rose initially, but tended to decrease late in the observation period and returned to control values within a 24-hr period. The magnitude of the effects of mefloquine MS appeared to be more dependent on the dose rate of drug delivery than on the total dose delivered.",
author = "Caldwell, {Robert W.} and Nash, {Clinton B.}",
year = "1977",
month = "6",
doi = "10.1016/0041-008X(77)90071-0",
language = "English (US)",
volume = "40",
pages = "437--448",
journal = "Toxicology and Applied Pharmacology",
issn = "0041-008X",
publisher = "Academic Press Inc.",
number = "3",

}

TY - JOUR

T1 - Pulmonary and cardiovascular effects of mefloquine methanesulfonate

AU - Caldwell, Robert W.

AU - Nash, Clinton B.

PY - 1977/6

Y1 - 1977/6

N2 - Mefloquine methanesulfonate (WR-142, 490·CH3SO3H), a highly effective antimalarial agent, when infused at a dose rate of 1 mg/kg/ min for 20 min in the anesthetized dog, caused either little or no effect on the pulmonary and cardiovascular parameters measured during this drug infusion or in the following 3-hr observation period. However, dose rates of 2 and 3 mg/kg/min of mefloquine MS for 20 min did produce pulmonary and cardiovascular changes. The respiratory parameters which were observed to change were: (1) tidal volume, which fell during the drug infusion but then returned to control values during the remaining portion of the observation period; (2) respiratory rate, which rose during the drug infusion, but returned to control values; (3) dynamic airways resistance, which decreased during drug administration, but then rose above control values; (4) small gradual changes in blood pO2 and pCO2. The cardiovascular parameters observed to change were: (1) arterial blood pressure, which decreased during the drug infusion, but returned rapidly to control values; (2) cardiac contractile force, which diminished during the drug infusion and returned toward control values later in the observation period; (3) central venous pressure, which rose transiently during drug administration; (4) pulmonary artery pressure, which rose initially, but tended to decrease late in the observation period and returned to control values within a 24-hr period. The magnitude of the effects of mefloquine MS appeared to be more dependent on the dose rate of drug delivery than on the total dose delivered.

AB - Mefloquine methanesulfonate (WR-142, 490·CH3SO3H), a highly effective antimalarial agent, when infused at a dose rate of 1 mg/kg/ min for 20 min in the anesthetized dog, caused either little or no effect on the pulmonary and cardiovascular parameters measured during this drug infusion or in the following 3-hr observation period. However, dose rates of 2 and 3 mg/kg/min of mefloquine MS for 20 min did produce pulmonary and cardiovascular changes. The respiratory parameters which were observed to change were: (1) tidal volume, which fell during the drug infusion but then returned to control values during the remaining portion of the observation period; (2) respiratory rate, which rose during the drug infusion, but returned to control values; (3) dynamic airways resistance, which decreased during drug administration, but then rose above control values; (4) small gradual changes in blood pO2 and pCO2. The cardiovascular parameters observed to change were: (1) arterial blood pressure, which decreased during the drug infusion, but returned rapidly to control values; (2) cardiac contractile force, which diminished during the drug infusion and returned toward control values later in the observation period; (3) central venous pressure, which rose transiently during drug administration; (4) pulmonary artery pressure, which rose initially, but tended to decrease late in the observation period and returned to control values within a 24-hr period. The magnitude of the effects of mefloquine MS appeared to be more dependent on the dose rate of drug delivery than on the total dose delivered.

UR - http://www.scopus.com/inward/record.url?scp=0017690780&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017690780&partnerID=8YFLogxK

U2 - 10.1016/0041-008X(77)90071-0

DO - 10.1016/0041-008X(77)90071-0

M3 - Article

C2 - 882980

AN - SCOPUS:0017690780

VL - 40

SP - 437

EP - 448

JO - Toxicology and Applied Pharmacology

JF - Toxicology and Applied Pharmacology

SN - 0041-008X

IS - 3

ER -